aspirin has been researched along with Active Hyperemia in 32 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to examine whether aspirin regulates vascular endothelial function following ischemia." | 9.16 | Regulation of blood flow by aspirin following muscle ischemia. ( Cameron, SJ; Goulopoulou, S; Kanaley, JA; Weil, BR, 2012) |
| "Effects of intracoronary aspirin on coronary blood flow and reactive hyperemia were evaluated in closed-chest, anesthetized dogs." | 7.67 | Attenuation of reactive hyperemia caused by aspirin in canine coronary artery. ( Aizawa, Y; Miyajima, S; Shibata, A, 1989) |
| "The purpose of this study was to examine whether aspirin regulates vascular endothelial function following ischemia." | 5.16 | Regulation of blood flow by aspirin following muscle ischemia. ( Cameron, SJ; Goulopoulou, S; Kanaley, JA; Weil, BR, 2012) |
| "The symptom scores for flushing, itching, tingling, and warmth were all significantly reduced by both aspirin regimens (p < ." | 5.08 | Effect of two aspirin pretreatment regimens on niacin-induced cutaneous reactions. ( Campbell, JR; Jungnickel, PW; Maloley, PA; Peddicord, TE; Vander Tuin, EL, 1997) |
| " Flow-dependent dilatation was evaluated before and after L-NMMA or aspirin as the response of the radial artery to an acute increase in flow (reactive hyperemia after a 3-minute cuff wrist occlusion)." | 3.69 | Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. ( Bakkali, EH; Haefeli, WE; Joannides, R; Linder, L; Lüscher, TF; Richard, V; Thuillez, C, 1995) |
| "Effects of intracoronary aspirin on coronary blood flow and reactive hyperemia were evaluated in closed-chest, anesthetized dogs." | 3.67 | Attenuation of reactive hyperemia caused by aspirin in canine coronary artery. ( Aizawa, Y; Miyajima, S; Shibata, A, 1989) |
| "After short episodes of reactive hyperemia, FMD was abolished by local infusion of the nitric oxide synthesis inhibitor N:(G)monomethyl-L-arginine (5." | 2.70 | Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia. ( Cross, J; Deanfield, JE; Donald, AE; Kharbanda, RK; MacAllister, RJ; Mullen, MJ; Taylor, M; Vallance, P, 2001) |
| "Ibuprofen was the most efficient agent, inhibiting the total reactive hyperemia by more than 70%, and naproxen was least active, producing about 35% inhibition." | 2.65 | Effect of different prostaglandin synthesis inhibitors on post-occlusive blood flow in human forearm. ( Carlsson, I; Wennmalm, A, 1983) |
| "During reactive hyperemia, plasma endothelin was reduced in normal subjects (-1." | 1.30 | Postischemic hyperemia in subjects with lower limbs obstructive arteriopathy: role of PGI2 and endothelin. ( Arosio, E; Lechi, A; Minuz, P; Pancera, P; Ribul, M; Rossi, L, 1997) |
| " Dose-response experiments performed with 2 to 90 per cent (v/v) zymosan-activated plasma showed a direct correlation between the rate of neutrophil influx and the degree of vascular permeability in blood flow." | 1.26 | Vascular responses during acute neutrophilic inflammation. Their relationship to in vivo neutrophil emigration. ( Issekutz, AC, 1981) |
| "Pretreatment with aspirin plus iridectomy virtually eliminates the elevation of intraocular pressure consequent to paracentesis." | 1.26 | Increased pressure after paracentesis of the rabbit eye is completely accounted for by prostaglandin synthesis and release plus pupillary block. ( Al-Ghadyan, A; Mead, A; Sears, M, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (40.63) | 18.7374 |
| 1990's | 8 (25.00) | 18.2507 |
| 2000's | 7 (21.88) | 29.6817 |
| 2010's | 3 (9.38) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Oncel, S | 1 |
| Gupta, R | 1 |
| Wang, Q | 1 |
| Basson, MD | 1 |
| Dahmus, JD | 1 |
| Bruning, RS | 1 |
| Kenney, WL | 1 |
| Alexander, LM | 1 |
| Rousseau, P | 1 |
| Mahé, G | 1 |
| Fromy, B | 1 |
| Ducluzeau, PH | 1 |
| Saumet, JL | 1 |
| Abraham, P | 1 |
| Furuno, T | 1 |
| Yamasaki, F | 1 |
| Yokoyama, T | 1 |
| Sato, K | 1 |
| Sato, T | 1 |
| Doi, Y | 1 |
| Sugiura, T | 1 |
| Cameron, SJ | 1 |
| Goulopoulou, S | 1 |
| Weil, BR | 1 |
| Kanaley, JA | 1 |
| COHEN, Y | 1 |
| LAPRAND, J | 1 |
| Golay, S | 1 |
| Haeberli, C | 1 |
| Delachaux, A | 2 |
| Liaudet, L | 2 |
| Kucera, P | 1 |
| Waeber, B | 2 |
| Feihl, F | 2 |
| Gooding, KM | 1 |
| Hannemann, MM | 1 |
| Tooke, JE | 2 |
| Clough, GF | 1 |
| Shore, AC | 1 |
| Addor, G | 1 |
| Dischl, B | 1 |
| Hayoz, D | 1 |
| Cragg, A | 1 |
| Einzig, S | 1 |
| Rysavy, J | 1 |
| Castaneda-Zuniga, W | 1 |
| Borgwardt, B | 1 |
| Amplatz, K | 1 |
| Carlsson, I | 1 |
| Wennmalm, A | 1 |
| Menys, VC | 1 |
| Tindall, H | 1 |
| Feely, M | 1 |
| Davies, JA | 1 |
| Issekutz, AC | 1 |
| Iwata, F | 1 |
| Zhang, XY | 1 |
| Leung, FW | 1 |
| Joannides, R | 1 |
| Haefeli, WE | 1 |
| Linder, L | 1 |
| Richard, V | 1 |
| Bakkali, EH | 1 |
| Thuillez, C | 1 |
| Lüscher, TF | 1 |
| De Santo, NG | 1 |
| Calò, L | 1 |
| Coppola, S | 1 |
| Anastasio, P | 1 |
| Cantaro, S | 1 |
| Favaro, S | 1 |
| Capasso, G | 1 |
| Borsatti, A | 1 |
| Pancera, P | 1 |
| Minuz, P | 1 |
| Rossi, L | 1 |
| Ribul, M | 1 |
| Arosio, E | 1 |
| Lechi, A | 1 |
| Jungnickel, PW | 1 |
| Maloley, PA | 1 |
| Vander Tuin, EL | 1 |
| Peddicord, TE | 1 |
| Campbell, JR | 1 |
| Andrieu, S | 1 |
| Lebret, M | 1 |
| Maclouf, J | 1 |
| Bévérelli, F | 1 |
| Giudicelli, JF | 1 |
| Berdeaux, A | 1 |
| Skyrme-Jones, RA | 1 |
| O'Brien, RC | 1 |
| Meredith, IT | 1 |
| Mullen, MJ | 1 |
| Kharbanda, RK | 1 |
| Cross, J | 1 |
| Donald, AE | 1 |
| Taylor, M | 1 |
| Vallance, P | 1 |
| Deanfield, JE | 1 |
| MacAllister, RJ | 1 |
| Dulou, R | 1 |
| Hauret, L | 1 |
| Renard, JL | 1 |
| Valle, JN | 1 |
| Béquet, D | 1 |
| Felten, D | 1 |
| Andersson, RG | 1 |
| Aberg, G | 1 |
| Brattsand, R | 1 |
| Ericsson, E | 1 |
| Lundholm, L | 1 |
| De Mey, C | 1 |
| Wellens, D | 1 |
| Vanhoutte, PM | 1 |
| Al-Ghadyan, A | 1 |
| Mead, A | 1 |
| Sears, M | 1 |
| Obstbaum, SA | 1 |
| Podos, SM | 1 |
| Salem, H | 1 |
| Dunn, BJ | 1 |
| Loux, JJ | 1 |
| Misra, R | 1 |
| Pandey, H | 1 |
| Chandra, M | 2 |
| Agarwal, PK | 1 |
| Pandeya, SN | 1 |
| Abignente, E | 1 |
| Arena, F | 1 |
| Luraschi, E | 1 |
| De Caprariss, P | 1 |
| Marmo, E | 1 |
| Vitagliano, S | 1 |
| Donnoli, D | 1 |
| Miyajima, S | 1 |
| Aizawa, Y | 1 |
| Shibata, A | 1 |
| Bates, ER | 1 |
| McGillem, MJ | 1 |
| Beals, TF | 1 |
| DeBoe, SF | 1 |
| Mikelson, JK | 1 |
| Mancini, GB | 1 |
| Vogel, RA | 1 |
| Ashley, SW | 1 |
| Sonnenschein, LA | 1 |
| Cheung, LY | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cerebral Vasodilator Responses in Sedentary and Exercise Trained Humans[NCT02653638] | Early Phase 1 | 80 participants (Actual) | Interventional | 2016-06-30 | Completed | ||
| Efficacy of L-arginine Treatment on Blood Pressure Control Patients With Stage 1 Hypertension[NCT02894723] | Phase 4 | 40 participants (Anticipated) | Interventional | 2016-09-30 | Not yet recruiting | ||
| The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in Humans[NCT02490124] | 7 participants (Actual) | Observational | 2014-12-31 | Completed | |||
| Single-centre, Single-blind, Randomized, Controlled, Cross-over Study to Analyze the Influence of Nitric Oxide on Flow Mediated Dilation[NCT03723278] | 20 participants (Actual) | Observational | 2018-11-14 | Completed | |||
| An Observational Study of Cardiovascular Complications of Carfilzomib Treatment in Clinical Practice[NCT03543579] | 46 participants (Anticipated) | Observational | 2017-03-23 | Active, not recruiting | |||
| The Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults With Type 1 Diabetes[NCT03174288] | 32 participants (Actual) | Interventional | 2015-08-31 | Completed | |||
| Regulation of Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease: A Mechanistic Approach[NCT01398943] | 60 participants (Actual) | Interventional | 2010-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Brachial artery FMD induced by reactive hyperemia will be used to assess vascular endothelial function at baseline and several hours after each experimental intervention. (NCT01398943)
Timeframe: Post FMD was taken approximately 110 min after baseline
| Intervention | percentage of change in FMD (Mean) | |
|---|---|---|
| Placebo | AOC Treatment | |
| All Controls | 6.7 | 6.9 |
| All COPD Patients | 3.1 | 4.7 |
A measure of vascular stiffness at baseline and several hours after each experimental intervention. (NCT01398943)
Timeframe: Post PWV was taken approximately 90 min after baseline
| Intervention | m/sec (Mean) | |
|---|---|---|
| Placebo | AOC Treatment | |
| All Controls | 11 | 10 |
| All COPD Patients | 14 | 11 |
1 review available for aspirin and Active Hyperemia
| Article | Year |
|---|---|
Physiopathology and pharmacotherapy of occlusive arterial disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Platelets; Blood Viscosity; Cerebrovas | 1979 |
7 trials available for aspirin and Active Hyperemia
| Article | Year |
|---|---|
Oral clopidogrel improves cutaneous microvascular function through EDHF-dependent mechanisms in middle-aged humans.
Topics: Administration, Oral; Analysis of Variance; Aspirin; Biological Factors; Blood Flow Velocity; Clopid | 2013 |
Effects of various doses of aspirin on platelet activity and endothelial function.
Topics: Adult; Analysis of Variance; Aspirin; Blood Platelets; Brachial Artery; Dose-Response Relationship, | 2011 |
Regulation of blood flow by aspirin following muscle ischemia.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Aspirin; Body Composition; Cholest | 2012 |
Maximum skin hyperaemia induced by local heating: possible mechanisms.
Topics: Aspirin; Cetirizine; Cross-Over Studies; Cyclic GMP; Cyclooxygenase Inhibitors; Double-Blind Method; | 2006 |
Effect of different prostaglandin synthesis inhibitors on post-occlusive blood flow in human forearm.
Topics: Adolescent; Adult; Aspirin; Cyclooxygenase Inhibitors; Diclofenac; Female; Forearm; Humans; Hyperemi | 1983 |
Effect of two aspirin pretreatment regimens on niacin-induced cutaneous reactions.
Topics: Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Over Stud | 1997 |
Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia.
Topics: Acetylcholine; Adolescent; Adult; Area Under Curve; Aspirin; Autonomic Agents; Blood Flow Velocity; | 2001 |
24 other studies available for aspirin and Active Hyperemia
| Article | Year |
|---|---|
ZINC40099027 Promotes Gastric Mucosal Repair in Ongoing Aspirin-Associated Gastric Injury by Activating Focal Adhesion Kinase.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Line; Creatini | 2021 |
Axon-reflex cutaneous vasodilatation is impaired in type 2 diabetic patients receiving chronic low-dose aspirin.
Topics: Acetylcholine; Aspirin; Axons; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Electric | 2009 |
[Study, by means of chromium 51, of bleeding from the digestive tract and gastric hyperemia induced in the rat by the administration of aspirin].
Topics: Animals; Aspirin; Blood Volume Determination; Chromium; Chromium Isotopes; Erythrocytes; Gastrointes | 1963 |
Local heating of human skin causes hyperemia without mediation by muscarinic cholinergic receptors or prostanoids.
Topics: Acetylcholine; Administration, Oral; Adult; Aspirin; Cyclooxygenase Inhibitors; Forearm; Glycopyrrol | 2004 |
A comparative study of reactive hyperemia in human forearm skin and muscle.
Topics: Administration, Oral; Adolescent; Adult; Aspirin; Blood Flow Velocity; Cyclooxygenase Inhibitors; Fo | 2008 |
Effect of aspirin on angioplasty-induced vessel wall hyperemia.
Topics: Angioplasty, Balloon; Animals; Arachidonic Acids; Aspirin; Carotid Arteries; Dilatation; Dogs; Hemod | 1983 |
Aspirin, prostacyclin and post-occlusive reactive hyperaemia in man.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Blood Platelets; Epoprostenol; Humans; Hyperemia; Male | 1982 |
Vascular responses during acute neutrophilic inflammation. Their relationship to in vivo neutrophil emigration.
Topics: Animals; Aspirin; Capillary Permeability; Cell Movement; Chemotactic Factors; Escherichia coli; Hype | 1981 |
Aggravation of gastric mucosal lesions in rat stomach by tobacco cigarette smoke.
Topics: Animals; Aspirin; Ethanol; Gastric Mucosa; Hydrogen; Hyperemia; Male; Nicotiana; Nicotine; Plants, T | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Topics: Adult; Arginine; Aspirin; Blood Pressure; Epoprostenol; Female; Forearm; Heart Rate; Humans; Hyperem | 1995 |
Renal prostaglandins and thromboxane A2 lack a functional significance in the genesis of protein-induced glomerular hyperfiltration in human renal disease.
Topics: Adult; Arachidonic Acids; Aspirin; Dietary Proteins; Dinoprost; Dinoprostone; Female; Glomerular Fil | 1993 |
Postischemic hyperemia in subjects with lower limbs obstructive arteriopathy: role of PGI2 and endothelin.
Topics: Aged; Arteriosclerosis; Aspirin; Endothelins; Epoprostenol; Hemodynamics; Humans; Hyperemia; Ilopros | 1997 |
Effects of antiaggregant and antiinflammatory doses of aspirin on coronary hemodynamics and myocardial reactive hyperemia in conscious dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Bradykinin; Coronary Disease; Coronary Vessels; Cycl | 1999 |
Vasodilator prostanoids, but not nitric oxide, may account for skeletal muscle hyperaemia in Type I diabetes mellitus.
Topics: Adult; Area Under Curve; Aspirin; Case-Control Studies; Cyclooxygenase Inhibitors; Diabetes Mellitus | 2000 |
[Pulsating exophtalmos and contralateral carotid-cavernous fistula].
Topics: Aged; Aspirin; Blepharoptosis; Carotid-Cavernous Sinus Fistula; Cavernous Sinus Thrombosis; Conjunct | 2002 |
Studies on the mechanism of flush induced by nicotinic acid.
Topics: Animals; Aspirin; Cyclic AMP; Cyclooxygenase Inhibitors; Drug Interactions; Ear, External; Female; G | 1977 |
Increased pressure after paracentesis of the rabbit eye is completely accounted for by prostaglandin synthesis and release plus pupillary block.
Topics: Animals; Aqueous Humor; Aspirin; Eye Proteins; Hyperemia; Intraocular Pressure; Iris; Prostaglandins | 1979 |
Ocular compression and noncorticosteroidal anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Conjunctiva; Eye Diseases; Humans; Hyperemia; Indomethac | 1975 |
Conjunctival temperature: a measure of ocular decongestant and anti-inflammatory activity.
Topics: Administration, Oral; Administration, Topical; Animals; Antazoline; Anti-Inflammatory Agents; Aspiri | 1975 |
Effects of commonly used non steroidal anti-inflammatory drugs on gastric mucosa. A clinical, endoscopic and histopathological study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug E | 1990 |
Research on heterocyclic compounds. XXVI. Antiinflammatory and related activities of some 2-phenylimidazo[1,2-b]pyridazines.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Carrageenan; | 1990 |
Attenuation of reactive hyperemia caused by aspirin in canine coronary artery.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Coronary Circulation; Depression, Chemical; D | 1989 |
Effect of angioplasty-induced endothelial denudation compared with medial injury on regional coronary blood flow.
Topics: Angioplasty, Balloon; Animals; Aspirin; Coronary Circulation; Coronary Vessels; Dogs; Endothelium; F | 1987 |
Focal gastric mucosal blood flow at the site of aspirin-induced ulceration.
Topics: Animals; Aspirin; Dogs; Gastric Mucosa; Hyperemia; Methods; Regional Blood Flow; Stomach; Stomach Ul | 1985 |